This federal contract award, valued at $17,792.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FGR57) with a firm fixed-price, non-set-aside contract type. It covers the delivery of 4,567,996,469 units of the prescription medication Tafinlar 75 mg capsule, with a performance period extending through May 13, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,792.84, is for the supply of Tafinlar 75 mg capsules. It is a firm-fixed price, delivery order contract with an ultimate completion date of April 22, 2025. The contract does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of 4,566,023,653 units of the cancer medication Tafinlar 75 mg capsules. The award has a ceiling value of $8,139.33 and runs through October 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,139.33 firm fixed-price contract is for the delivery of 120 capsules of the drug Tafinlar 75 mg. The ultimate completion date for this order is April 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TAFINLAR 75 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,139.33 and an ultimate completion date of November 5, 2024. Amerisourcebergen, through its Corporate Office division, will supply this medication to support military treatment facilities and other federal healthcare providers....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,139.33 Firm Fixed Price delivery order is for the provision of 120 count bottles of the prescription drug Tafinlar 75 mg capsules. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,822.16 Firm Fixed Price Delivery Order contract covers the provision of 4561377577 TAFINLAR 75 MG CAPSULE 120S, with a period of performance through July 21, 2023. The contract is not designated under any set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...